EMERYVILLE, CA, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Hypothesis™, a precision skincare brand built on patented enzyme technology, has been named Best Exfoliating Cleanser in the 2026 Cosmopolitan Acne Awards for its Daily Acne Cleanser. The clinically tested formula exfoliates clogged pores, removes excess oil and helps reduce breakouts without drying the skin.
Cosmopolitan magazine is one of the nation's leading women's lifestyle publications, reaching millions of readers across its print, digital and social platforms. Its annual Acne Awards recognize standout skincare products that the magazine's expert beauty editors personally test and select.
“We're thrilled to have the hypothesis™ Daily Acne Cleanser recognized by Cosmopolitan as one of the best products for acne-prone skin,” said Oliver Liu, PhD, co-founder of hypothesis™. “Treating acne shouldn't mean trading breakouts for dry, irritated skin. We developed this cleanser to clear pores and reduce breakouts while being gentle enough for everyday use. It's part of our larger mission to make skincare smarter, more precise and better for the skin.”
Clinically Proven Exfoliation Without the Harsh Side Effects
The hypothesis™ Daily Acne Cleanser combines 1% salicylic acid to unclog pores and clear breakouts while glycolic acid gently exfoliates dead skin cells and improves uneven tone. Zinc helps control excess oil, while tea tree oil and aloe help soothe acne-prone skin.
In a clinical trial of 32 adults with mild to severe acne, 100% had reduced skin oiliness after using the cleanser for four weeks. Additionally, 91% reported cleaner pores and found the cleanser gentle enough to use twice daily.
The cleanser, available for $29.99, is dermatologist-approved, hypoallergenic and non-comedogenic, and formulated without added fragrance, benzoyl peroxide, drying alcohols, dyes or sulfates.
Part of a Complete Precision Acne Routine
The Daily Acne Cleanser is the first step in the Hypothesis™ Precision Acne Routine, an easy three-step system designed to treat breakouts while preserving the skin's beneficial microbiome. The cleanser prepares skin for Acne Precision Serum, which delivers the brand's patented CUT-02™ enzyme technology. In laboratory testing, CUT-02™ selectively eliminated 99.9% of acne-associated C. acnes bacteria within one hour without harming beneficial bacteria. The Balancing + Brightening Gel Cream completes the routine with hydration and skin barrier support.
This three-step routine is available for $89.99 (a $109.97 value) and comes with a 60-day money-back guarantee.
For more information or to purchase products, visit www.hypothesis.bio or Ulta.
About hypothesis™
Founded in 2022 and based in Emeryville, CA, hypothesis™ is a precision skincare company developing patented enzyme-based products that selectively target the bacteria associated with inflammatory skin conditions such as eczema and acne while preserving the broader skin microbiome. Its formulas have earned the National Eczema Association Seal of Acceptance, EWG Verified®, Microbiome Friendly for Eczema certification from MyMicrobiome, and Leaping Bunny Certified status. Visit us at www.hypothesis.bio.
Attachment
- Hypothesis™ Daily Acne Cleanser named Best Exfoliating Cleanser in the 2026 Cosmopolitan Acne Awards
Jo-Anne Coombes hypothesis jo-anne.coombes@TeamBespoke.com
